Login / Signup

Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial.

Merel J l'AmiCharlotte Lm KrieckaertMichael T NurmohamedRonald F van VollenhovenTheo RispensMaarten BoersGerrit Jan Wolbink
Published in: Annals of the rheumatic diseases (2017)
NTR3509; Results.
Keyphrases
  • clinical trial
  • open label
  • double blind
  • phase ii
  • rheumatoid arthritis
  • study protocol
  • juvenile idiopathic arthritis
  • phase iii
  • placebo controlled
  • ulcerative colitis
  • randomized controlled trial